26.58
1.49%
0.3906
시간 외 거래:
26.58
0.0028
+0.01%
Tema Neuroscience And Mental Health Etf 주식(MNTL)의 최신 뉴스
Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says - CNBC
Where to Invest in Health Trends - Bloomberg
Tema ETFs CIO on Investment Opportunities in Biotech - Opto RoW
Biogen cost cuts drive profit beat, as Alzheimer's drug off to slow start - MSN
Vertex's Pain Drug Could Be Worth Up To $11.4 Billion — Ongoing Debate Sparks Shares - MSN
Vertex Stock Sparks As Debate Rages Over Potential Blockbuster Pain Drug - Investor's Business Daily
Vertex shares flat on repeat guidance despite first-quarter gainsTHE BHARAT EXPRESS NEWS - The Bharat Express News
Healthcare ETFs for the Weight-Loss Drug Boom & Beyond - Yahoo Finance
Benzinga's 2024 Virtual Healthcare Summit: What's Next In Health? - Benzinga
'This is the mental health moment': Innovation and M&A are helping to boost these stocks to new heights - CNBC
Introducing the Tema Neuroscience and Mental Health ETF (MNTL) - NEWS CHANNEL NEBRASKA
Introducing the Tema Neuroscience and Mental Health ETF (MNTL), Business Wires News - AsiaOne
This Week in ETFs: Closures Outnumber New ETFs - ETF Trends
US ETF launches from 18th to 25th January, 2024 - ETF Express
Best Stocks Under $50 Right Now - Benzinga
자본화:
|
볼륨(24시간):